If you are attending #BioEquityEurope2024, come and meet our CEO, Miquel Vila-Perello and CBO, Gerard Caelles, next week in San Sebastian! Join Miquel on 13 May, where he will participate on a panel, titled ‘Scaling Up Europe’s Academic Engine in Cell and Gene Therapy' where he will provide his thoughts on the current cell and gene therapy landscape at 11:15 CEST. At 15:45 CEST on 13 May, Miquel will present 🎤 on SpliceBio's proprietary Protein Splicing platform and lead #GeneTherapy program, SB007, where he will provide an update on the Company's latest developments. Schedule a 1-1 meeting with the team at BioEquity via the online partnering portal here https://bit.ly/3JJQ0r1 or reach out directly via LinkedIn. Revolutionizing genetic medicine with its proprietary Protein Splicing platform! #biotech #retinaldiseases #lifesciences #ProteinSplicing #genetherapy
SpliceBio’s Post
More Relevant Posts
-
We've had a great start of 5th Gene Therapy Analytical Development Europe Summit with pre-conference workshop on Innovations in Partial Capsid Characterization, co-moderated with Ishtiaq Khaliq. Detailed characterization of partially filled AAV capsids is becoming more and more important, together with characterization of vector genome integrity. Tomorrow I will also present data on novel approaches for quantification of genome integrity without DNA amplification using Gator Bio's biolayer interferometry platform. #AAV #genomeintegrity #gatorbio #GTAD #hansonwade
-
-
👁️ Dive into the world of retinitis pigmentosa (RP) with Dr. Reza Rezarei from Cyagen! 🎥 In this insightful video, Dr. Rezarei sheds light on RP, a group of rare inherited disorders causing vision loss. Discover how Cyagen's HUGO-GT model, specifically the B6J-hRHO mice, is revolutionizing gene therapy development for RP. Watch now and join us in our mission to understand and conquer RP! 🧬 #RetinitisPigmentosa #GeneTherapy #Cyagen #HUGOGT #VisionResearch #Research #researchanddevelopment #biotech #biotechnology #sciencecommunication #preclinical #preclinicalresearch
-
Absolute game changer: the latest addition to the #Verickeck #ddPCR kit family, Empty Full Capsid kit, enabling precise determination of capsid titre, genome titre and percentage of full capsids in AAV samples. Check out the data. #geneTherapy #qualitycontrol #biorad #ddpcr
📢Exciting News! Product Announcement: https://lnkd.in/g-KhnEhg Bio-Rad is excited to announce the launch of the Vericheck ddPCR Empty-Full Capsid Kit, enabling precise determination of capsid titer, genome titer, and the percentage of full capsids in both purified and unpurified (crude lysate) AAV samples. Designed for use on Bio-Rad’s Droplet Digital PCR Systems, the kit offers a cost-effective and streamlined solution for gene therapy development, delivering robust, reproducible data with minimal sample amounts and ensuring reliable assessment of AAV vector quality. #LifeSciences #QualityControl #GeneTherapy
-
-
Today's the day! We have been asked a lot about the new Vericheck Empty-Full #Capsid kit and it has finally been launched today! It is going to help so many #genetherapy labs with their workflows. If you would like more information, send me a message. #biorad #cellandgenetherapy #AAV #emptyfull #therapy #science
📢Exciting News! Product Announcement: https://lnkd.in/g-KhnEhg Bio-Rad is excited to announce the launch of the Vericheck ddPCR Empty-Full Capsid Kit, enabling precise determination of capsid titer, genome titer, and the percentage of full capsids in both purified and unpurified (crude lysate) AAV samples. Designed for use on Bio-Rad’s Droplet Digital PCR Systems, the kit offers a cost-effective and streamlined solution for gene therapy development, delivering robust, reproducible data with minimal sample amounts and ensuring reliable assessment of AAV vector quality. #LifeSciences #QualityControl #GeneTherapy
-
-
Product characterization utilizing long read sequencing data can offer critical insights into the quality, safety and manufacturability of gene therapy vector designs. Form Bio provides comprehensive characterization reports that offer key insights to assess the extent of “error-prone” genome encapsulation during rAAV production. For instance, in an rAAV vector (described in the report), we found 97.61% self-complementary double-stranded genome structure, 1.72% single-stranded genome structure and 95.17% full-length drug product. Additionally, we identified 0.67% total contamination, of which 0.01% originated from the host genome. What actions would you take with this level of clarity? Explore a preview of our sample product characterization report, or get in touch to review a complete report: https://hubs.li/Q02tFtS-0
-
-
🔍Precision in Gene Editing with NGS-Verified Engineered Cells 🧬 At EditCo Bio, accuracy is our top priority. Our engineered cell lines go through rigorous NGS verification, so you know every edit is exactly on point. Take your research to the next level with confidence and unmatched precision. Check out our latest blog on how #NGS is advancing genome engineering and how our cell lines can elevate your discoveries: https://hubs.la/Q02SX4yj0 #CRISPR #EngineeredCells #DrugDiscovery
-
-
Global Product Management|Global Marketing|Leadership|Life Sciences|Genomics|Multiomics|Diagnostics|
Join us to learn more about Advancing Protein Research with Simple Western
Join us on October 24 for an exclusive webinar introducing the newest member of the Simple Western family – the Leo™ System! Discover how this new system can transform western blots into quantitative bioanalytical methods suitable for adoption for robust quantitative measures of protein expression ranging from gene therapy potency to TPD studies. 🧪🔬 👉 Don’t miss this opportunity to learn how Simple Western is paving the way for faster and more reliable protein research. Register now: https://bit.ly/3ZGfTkS #SimpleWestern #Bio-techne #genetherapy #TPD #Webinar
-
-
📣 We are kicking off the fall conference season with BPI Boston! Looking to drive up batch productivity and drive down manufacturing COGS? Here are two ways our Viral Sensitizers (VSEᵀᴹ) cell enhancers can tackle the challenge of innate cellular defenses during cell and gene therapy (CGT) production: ✔ A tailored formulation of VSEs optimized for your platform, cell substrate and viral product. ✔ Achieve higher yields and improved quality - validated in 50+ applications across cell lines and viral products. 💡 Unlock the potential of your production platform with our VSEs and Design of Experiments (DoE) expertise to optimize viral vector production and boost viral yields rapidly. 🤝 If you are attending, swing by booth #1811! We'd love to chat! Check out our technology: https://lnkd.in/gu2m3RcX #biomanufacturing #BPIBoston #innovation #biotechnology
-
-
Check out this webinar featuring Leo data.
Join us on October 24 for an exclusive webinar introducing the newest member of the Simple Western family – the Leo™ System! Discover how this new system can transform western blots into quantitative bioanalytical methods suitable for adoption for robust quantitative measures of protein expression ranging from gene therapy potency to TPD studies. 🧪🔬 👉 Don’t miss this opportunity to learn how Simple Western is paving the way for faster and more reliable protein research. Register now: https://bit.ly/4dkttxh #SimpleWestern #Bio-techne #genetherapy #TPD #Webinar
-
-
You are invited to the Biophysical Summit hosted by Applied Photophysics and KBI Biopharma! 🏔 Join us for an interactive workshop to discuss best practices for Biophysical Characterisation. Hear from recognized experts about critical regulatory expectations and the best practices for the characterisation of higher order structure of molecules. This summit will highlight some of the latest analytical techniques for developing and characterizing protein and gene therapies. Come with your questions and learn how companies tackle the characterization of novel modalities. Register here: https://bit.ly/3TYGnt9 #BiophysicalSummit #KBI #AppliedPhotophysics #Biophysics